Akebia Therapeutics to Report First Quarter 2021 Financial Results and Discuss Recent Business Highlights
- Wednesday, April 28, 2021, 7:15
- Environment
- Add a comment
CAMBRIDGE, Mass., April 28, 2021 /PRNewswire/ — Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced plans to release its financial results for the first quarter ended March 31,…
About the Author
adminasapcorp has written 41525 stories on this site.